Perpetual Ltd
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1647273
SYDNEY, NEW SOUTH WALES, C3
Position in ARQT
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$21,428,903
-$5,015,791 QoQ
Shares Held
909,546
-0.1% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Perpetual Ltd holds $140,374,445 across 12 Biotechnology names. ARQT ranks #4 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
140,885 | $26,634,309 | |
| 2 | INSM |
INSMED Inc
|
142,580 | $23,314,680 | |
| 3 | ASND |
Ascendis Pharma A/S
|
100,638 | $23,018,929 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
909,546 | $21,428,903 | |
| 5 | ARGX |
Argenx SE
|
28,359 | $20,709,159 | |
| 6 | GMAB |
Genmab A/S
|
758,503 | $20,350,635 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,145 | $1,657,312 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,690 | $890,040 |
All Filings in ARQT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,428,903 | 909,546 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $26,444,694 | 910,630 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $38,163,822 | 2,024,606 | Shares | Defined | 2025-10-10 | |
| 2025-06-30 | $371,810 | 26,520 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $414,772 | 26,520 | Shares | Defined | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||